San Francisco, CA, United States of America

John Vincent Fahy

This inventor holds 6 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: University of California, University College Dublin, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Vincent Fahy. Retrieved from https://idiyas.com/inventor/john-vincent-fahy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2018-2026

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: John Vincent Fahy: Innovator in Mucolytic Agents

Introduction

John Vincent Fahy is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of mucolytic agents, holding a total of 6 patents. His work focuses on methods to improve respiratory health by decreasing mucus viscosity and elasticity.

Latest Patents

Fahy's latest patents include innovative formulations and methods for mucolytic agents. One of his patents, titled "Dithiolsaccharide mucolytic agents and uses thereof," provides methods for decreasing mucus elasticity or viscosity in subjects. This involves administering an effective amount of a dithiolsaccharide mucolytic agent. Another significant patent is for "Thiosaccharide mucolytic agents," which similarly aims to reduce mucus viscosity through the administration of thiosaccharide mucolytic agents.

Career Highlights

Throughout his career, Fahy has worked with prestigious institutions such as the University of California and University College Dublin. His research has contributed to advancements in respiratory therapies and has had a positive impact on patient care.

Collaborations

Fahy has collaborated with notable colleagues, including Stefan Oscarson and Shaopeng Yuan. Their combined expertise has furthered the development of effective mucolytic treatments.

Conclusion

John Vincent Fahy is a distinguished inventor whose work in mucolytic agents has the potential to improve respiratory health significantly. His innovative patents and collaborations highlight his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…